Restoring SIRT6 levels in VSMCs attenuates atherosclerosis and preserves several features of plaque stability, indicating that protecting telomere damage and increasing SIRT6 represent novel targets for both prevention and treatment of atherosclerosis in humans. Here, SIRT6 is linked to atherosclerosis.